ReSET program to help stimulant use in HIV clinics
Part of Mental health clinical trials.
This study tests a care-support program called ReSET to improve adherence to treatment and reduce stimulant use for people living with HIV who are not currently in drug treatment. You may be offered support through HIV clinic care to help you stay on track, especially if you have access to a smartphone and stable housing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and were assigned male at birth (and have not taken transgender hormone treatment).
- You have had sex with a male in the last 12 months.
- You have a stimulant use disorder in the last 12 months and are not currently in drug treatment.
- You live with HIV and have an active prescription for antiretroviral (HIV) medicine.
- You have stable housing, a phone/tablet with reliable internet, and can read and understand English.
- You can attend the study and complete required check-in tasks (including baseline questions and a lab visit if asked).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone app (DynamiCare) to help people recovering from stimulant use (methamphetamine or cocaine) stay healthy after leaving jail or prison. It also focuses on those at risk for or living with HIV.
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
This study tests whether a program can reduce shame and stigma for people living with HIV who also have a substance use disorder. It may help you feel less judged and cope better, while supporting HIV care.
This study tests a program that uses rewards and emotional support to help people who use stimulants stay on track with HIV prevention. You'll get guidance through your smartphone, and the goal is to help you stay healthy and reduce your risk of getting HIV.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
This trial tests a program to help people with HIV stay on track with their medication. If you take HIV medication, sometimes miss doses, and use stimulants, this program may offer support to improve your health.
Hear when a new Stimulant Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.